Blueberries Medical Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBRRF research report →
Companyblueberriesmed.com
Blueberries Medical Corp. engages in the growth, cultivation, development, production, and supply of medicinal cannabis and related products in Colombia. It offers medicinal-grade cannabis oil extracts and related products.
- CEO
- Facundo Garreton
- IPO
- 2019
- HQ
- Bogotá, CO
Price Chart
Valuation
- Market Cap
- $6.14M
- P/E
- -2.97
- P/S
- 15.85
- P/B
- 15.42
- EV/EBITDA
- -3.87
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 31.93%
- Op Margin
- -441.57%
- Net Margin
- -533.44%
- ROE
- -208.29%
- ROIC
- -419.96%
Growth & Income
- Revenue
- $312.03K · -33.81%
- Net Income
- $-1,664,502 · -44.92%
- EPS
- $-0.00 · -17.24%
- Op Income
- $-1,377,831.2
- FCF YoY
- -55.87%
Performance & Tape
- 52W High
- $0.02
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 2.58
- Avg Volume
- 29.30K
Get TickerSpark's AI analysis on BBRRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BBRRF Coverage
We haven't published any research on BBRRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BBRRF Report →